Literature DB >> 34775120

Levels of depressed mood and low interest for two years after response to cognitive therapy for recurrent depression.

Jeffrey R Vittengl1, Lee Anna Clark2, Michael E Thase3, Robin B Jarrett4.   

Abstract

BACKGROUND: Major depressive disorder (MDD) involves depressed mood (high negative affect, predominantly) and low interest/pleasure (low positive affect). In past research, negative affect has improved more than positive affect during acute-phase antidepressant medication or cognitive therapy (CT). We extended this literature by differentiating depressed mood and two dimensions of low interest (general and sexual), assessing persistence of symptom differences after acute-phase CT response, and testing whether continuation treatment acted differently on depressed mood versus low interest.
METHODS: We analyzed data from two randomized controlled trials. Patients with recurrent MDD first received acute-phase CT. Then, responders were randomized to 8-month continuation treatments and assessed for 16-24 additional months.
RESULTS: Depressed mood and low general interest improved more than low sexual interest during acute-phase CT. Among responders, these symptom differences persisted for at least 2 years and were not changed by continuation CT or antidepressant medication. LIMITATIONS: Generalization of findings to other patient populations and treatments is uncertain. Depressed mood and low interest scales were constructed from standard symptom measures and overlapped empirically.
CONCLUSIONS: Less improvement during CT, and persistent low sexual interest despite continuation treatment, highlights the need for MDD treatments more effectively targeting this positive affective symptom.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anhedonia; Cognitive therapy; Continuation treatment; Depression; Negative affect; Positive affect

Mesh:

Substances:

Year:  2021        PMID: 34775120      PMCID: PMC8712398          DOI: 10.1016/j.brat.2021.103996

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  33 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

2.  Positive cognitive behavior therapy in the treatment of depression: A randomized order within-subject comparison with traditional cognitive behavior therapy.

Authors:  Nicole Geschwind; Arnoud Arntz; Fredrike Bannink; Frenk Peeters
Journal:  Behav Res Ther       Date:  2019-03-09

3.  Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo.

Authors:  Robin B Jarrett; Abu Minhajuddin; Howard Gershenfeld; Edward S Friedman; Michael E Thase
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

4.  Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial.

Authors:  R B Jarrett; D Kraft; J Doyle; B M Foster; G G Eaves; P C Silver
Journal:  Arch Gen Psychiatry       Date:  2001-04

Review 5.  Effectiveness of psychological interventions in preventing recurrence of depressive disorder: meta-analysis and meta-regression.

Authors:  Karolien E M Biesheuvel-Leliefeld; Gemma D Kok; Claudi L H Bockting; Pim Cuijpers; Steven D Hollon; Harm W J van Marwijk; Filip Smit
Journal:  J Affect Disord       Date:  2014-12-13       Impact factor: 4.839

Review 6.  Comorbidity of anxiety and unipolar mood disorders.

Authors:  S Mineka; D Watson; L A Clark
Journal:  Annu Rev Psychol       Date:  1998       Impact factor: 24.137

7.  Multiple measures, methods, and moments: a factor-analytic investigation of change in depressive symptoms during acute-phase cognitive therapy for depression.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Dolores Kraft; Robin B Jarrett
Journal:  Psychol Med       Date:  2005-05       Impact factor: 7.723

8.  More Than Just Sex: Affection Mediates the Association Between Sexual Activity and Well-Being.

Authors:  Anik Debrot; Nathalie Meuwly; Amy Muise; Emily A Impett; Dominik Schoebi
Journal:  Pers Soc Psychol Bull       Date:  2017-01-09

9.  Quantifying and qualifying the preventive effects of acute-phase cognitive therapy: Pathways to personalizing care.

Authors:  Robin B Jarrett; Abu Minhajuddin; Jeffrey R Vittengl; Lee Anna Clark; Michael E Thase
Journal:  J Consult Clin Psychol       Date:  2015-12-14

10.  The Inventory of Depressive Symptomatology (IDS): psychometric properties.

Authors:  A J Rush; C M Gullion; M R Basco; R B Jarrett; M H Trivedi
Journal:  Psychol Med       Date:  1996-05       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.